Manufacturing

Feb 23, 2018
By BioPharm International Editors
The contract development and manufacturing organization has entered it first manufacturing contract worth $148 million for its recently completed Plant 3 facility.
Feb 22, 2018
By BioPharm International Editors
The agreement follows the recent opening of WuXi STA's oligonucleotide R&D labs in China and the US.
Feb 22, 2018
By BioPharm International Editors
Avid Bioservices will provide commercial manufacture of an enzyme replacement therapy by Roivant Sciences' Enzyvant subsidiary.
Feb 22, 2018
By BioPharm International Editors
The new training center, the Jefferson Institute for Bioprocessing, will prepare engineering students and industry professionals for the field of biologics manufacturing.
Feb 22, 2018
By BioPharm International Editors
The company aims to add the additional analytical services in the European Union throughout 2018.
Feb 21, 2018
By BioPharm International Editors
The companies have partnered to develop and commercialize vectorized antibodies against tau for Alzheimer's and other neurodegenerative diseases.
Feb 20, 2018
By BioPharm International Editors
The study suggests that circumventing evolution in cell factories can enable the commercialization of new biobased chemicals to large-scale.
Feb 16, 2018
By BioPharm International Editors
The company has expanded its single-use manufacturing capabilities at its facility in Fermoy, Ireland.
Feb 15, 2018
By BioPharm International Editors
Fluarix Tetra has been approved for use in children aged six months and above.
Feb 14, 2018
By BioPharm International Editors
Ferring Pharmaceuticals will expand its biologics capabilities at its headquarters and manufacturing site in Saint-Prex, Switzerland.
native1_300x100
lorem ipsum